Related references
Note: Only part of the references are listed.Spline-based accelerated failure time model
Menglan Pang et al.
STATISTICS IN MEDICINE (2021)
Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
Wenbiao Chen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
Parametric survival model to identify the predictors of breast cancer mortality: An accelerated failure time approach
Zeinab Iraji et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2020)
RNA sequencing: the teenage years
Rory Stark et al.
NATURE REVIEWS GENETICS (2019)
Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma
Jian-Guo Zhou et al.
GYNECOLOGIC ONCOLOGY (2019)
Transcriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinoma
Huajing Teng et al.
THERANOSTICS (2018)
Power and sample size calculation for the additive hazard model
Pei-Fang Su
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2017)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
Ki-Tae Hwang et al.
JOURNAL OF BREAST CANCER (2017)
Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse
Salem Werdyani et al.
CANCER MEDICINE (2017)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco J. Candido-dos-Reis et al.
CLINICAL CANCER RESEARCH (2015)
Ward's Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward's Criterion?
Fionn Murtagh et al.
JOURNAL OF CLASSIFICATION (2014)
Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non-Small-Cell Lung Cancer Including Stage IA Patients
Sandy D. Der et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Testing the proportional hazards assumption in case-cohort analysis
Xiaonan Xue et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
Johan Botling et al.
CLINICAL CANCER RESEARCH (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Gene selection in microarray survival studies under possibly non-proportional hazards
Daniela Dunkler et al.
BIOINFORMATICS (2010)
Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
Carine A. Bellera et al.
BMC MEDICAL RESEARCH METHODOLOGY (2010)
Immortal time bias in critical care research: Application of time-varying Cox regression for observational cohort studies
Ayumi K. Shintani et al.
CRITICAL CARE MEDICINE (2009)
Survival end point reporting in randomized cancer clinical trials: A review of major journals
Simone Mathoulin-Pelissier et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution
Christopher Cox et al.
STATISTICS IN MEDICINE (2007)
Simple parallel statistical computing in R
A. J. Rossini et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2007)
Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
R. A. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2007)
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
GM Callagy et al.
CLINICAL CANCER RESEARCH (2006)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Share Paper
